CVS Health Corp. closed 34.84% short of its 52-week high of $80.75, which the company achieved on March 28th.
The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including ...
Adjusted per-share earnings in the fourth quarter for UnitedHealth top analysts’ estimates but revenue comes up short.
On the post-earnings call with analysts, Chief Executive Andrew Witty addressed the recent public backlash over high drug costs and transparency of coverage, particularly following killing of Brian ...
In its first results since its insurance unit CEO was fatally shot in New York City, UnitedHealth Group reported Thursday weaker-than-expected fourth-quarter revenue, prompting its shares to fall in ...
The top line of UnitedHealthcare, the company's insurance and managed care business, rose 6.1% to $74.1 billion. Analysts had been looking for $75.22 billion. Revenue from Optum, its ...
UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like ...
UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like Medicare funding cuts and a Medicaid enrollment drop hurt.
Shares of CVS Health Corp. CVS inched 0.10% higher to $51.57 Tuesday, on what proved to be an all-around positive trading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback